Glycophosphatidylinositol-anchored protein deficiency as a marker of Mutator phenotypes in cancer

Cancer Research

Volumn 61, Issue 2, 2001, Pages 654-658

  Chen, Rui ^a   Eshleman, James R ^a,c   Brodsky, Robert A ^b   Medof, M Edward ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROLYSIN; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; TUMOR MARKER;

ARTICLE; COLON CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MUTATION RATE; MUTATOR GENE; PHENOTYPE; PRIORITY JOURNAL;

ANTIGENS, CD55; ANTIGENS, CD59; BIOLOGICAL MARKERS; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GENE FREQUENCY; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; MEMBRANE PROTEINS; MUTATION; NEOPLASMS; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0035863311     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. The clonal evolution of tumor cell populations
2. Microsatellite instability: Marker of a mutator phenotype in cancer
3. Mutator phenotypes in human colorectal carcinoma cell lines
4. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer
5. Synthesis of the GPI anchor
6. Biosynthesis of glycosylphosphatidylinositols in mammals and unicellular microbes
7. The cloning of PIGA, a component in the early step of GPI-anchor biosynthesis
8. Deficiency of the GPI anchor caused by a somatic mutation of the PIGA gene in paroxysmal nocturnal hemoglobinuria
9. The molecular basis for paroxysmal nocturnal hemoglobinuria
10. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers
11. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria
12. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
13. Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement
14. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin
15. Derivation and characterization of glycoinositol-phospholipid anchor-defective human K562 cell clones
16. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer
17. Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instability
18. Flow cytometric enumeration of drug-resistant tumor cells
19. Ploidy dependence of induced mutation frequency in transformed Syrian hamster cells
20. Mutation assay at the thymidine locus in diploid human lymphoblasts
21. Leukemia arising out of paroxysmal nocturnal hemoglobinuria
22. DNA mismatch binding defects. DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines
23. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair